AVTX
Avalo Therapeutics, Inc. Common Stock
stockNASDAQ
cerecor inc. is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human brain. we are a delaware corporation, organized in april 2011 in partnership with various laboratories and research institutes at johns hopkins medical institute ("jhmi"). cerecor is focused on translational medicine – the accelerated transfer of technology from the academic laboratory to early human trials, with the goal of rapid commercialization. we acquire rights to early stage therapeutic technologies ("assets") from universities, finance and manage the development of these assets into drug candidates (to first major milestone or value inflection point) and then either commercialize or outlicense the asset.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 6.93 | 2026-11-06 | +11.90% | 5.731 |
| 1M | 12.01 | 2026-10-13 | -35.43% | 3.269 |
| 3M | 19.45 | 2026-08-13 | -60.13% | 2.490 |
| 6M | 19.85 | 2026-05-13 | -60.93% | 1.507 |
| 1Y | 14.73 | 2025-11-13 | -47.35% | 1.426 |
| 2Y | 13.40 | 2024-11-13 | -42.13% | — |
| 5Y | 6,595.20 | 2021-11-12 | -99.88% | 0.882 |
Avalo Therapeutics, Inc. Common Stock (NASDAQ:AVTX) stock price today is $7.76, and today's volume is 814,658. AVTX is up 0.714% today. The 30 day average volume is 2.54M. AVTX market cap is $448.42M with 57.82M shares outstanding.